HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression

Cited by (1,008)

Items 101–200 of 1,008

1. Ruthenium-Based Photoactivated Chemotherapy
   Sylvestre Bonnet · 2023 · Journal of the American Chemical Society
2. Hif1a Deletion Reveals Pro-Neoplastic Function of B Cells in Pancreatic Neoplasia
   Kyoung Eun Lee, Michelle Spata, Lauren J. Bayne, Elizabeth L. Buza, Amy C. Durham, David Allman, Robert H. Vonderheide, Marie Celeste Simon · 2015 · Cancer Discovery
3. STAT3 and HIF1α cooperatively activate HIF1 target genes in MDA-MB-231 and RCC4 cells
   Matthew R. Pawlus, L Wang, Cheng‐Jun Hu · 2013 · Oncogene
4. The SWI/SNF Protein PBRM1 Restrains VHL-Loss-Driven Clear Cell Renal Cell Carcinoma
   Amrita M. Nargund, Can G. Pham, Yiyu Dong, Patricia I. Wang, Hatice U. Osmangeyoglu, Yuchen Xie, Ömer Aras, Song Han, Toshinao Oyama, Shugaku Takeda et al. · 2017 · Cell Reports
5. A Clearer View of the Molecular Complexity of Clear Cell Renal Cell Carcinoma
   Ian J. Frew, Holger Moch · 2014 · Annual Review of Pathology Mechanisms of Disease
6. HIF-2α activation potentiates oxidative cell death in colorectal cancers by increasing cellular iron
   Singhal, Rashi, Mitta, Sreedhar R., Das, Nupur K., Kerk, Samuel A., Sajjakulnukit, Peter, Solanki, Sumeet, Andren, Anthony, Kumar, Roshan, Olive, Kenneth P., Banerjee, Ruma et al. · 2021 · Journal of Clinical Investigation
7. The Meaning, Measurement and Modification of Hypoxia in the Laboratory and the Clinic
   Ester M. Hammond, Marie‐Claude Asselin, Duncan M. Forster, James P.B. O’Connor, Joana M. Senra, Kaye Janine Williams · 2014 · Clinical Oncology
8. Acute vs. Chronic vs. Cyclic Hypoxia: Their Differential Dynamics, Molecular Mechanisms, and Effects on Tumor Progression
   Kritika Saxena, Mohit Kumar Jolly · 2019 · Biomolecules
9. Macrophage metabolic reprogramming presents a therapeutic target in lupus nephritis
   Chenzhi Jing, Tomas Castro‐Dopico, Nathan Richoz, Zewen Kelvin Tuong, John R. Ferdinand, Laurence S. C. Lok, Kevin W. Loudon, Gemma D. Banham, Rebeccah J. Mathews, M. Zaeem Cader et al. · 2020 · Proceedings of the National Academy of Sciences
10. AMPK–mTOR Signaling and Cellular Adaptations in Hypoxia
    Yoomi Chun, Joungmok Kim · 2021 · International Journal of Molecular Sciences
11. Hypoxia/pseudohypoxia‐mediated activation of hypoxia‐inducible factor‐1α in cancer
    Yoshihiro Hayashi, Asumi Yokota, Hironori Harada, Gang Huang · 2019 · Cancer Science
12. USP22 promotes hypoxia-induced hepatocellular carcinoma stemness by a HIF1α/USP22 positive feedback loop upon TP53 inactivation
    Sunbin Ling, Qiaonan Shan, Qifan Zhan, Qianwei Ye, Peng Liu, Shengjun Xu, Xin He, Jian Ma, Jiajia Xiang, Guangjiang Jiang et al. · 2019 · Gut
13. Undercover: gene control by metabolites and metabolic enzymes
    Jan A. van der Knaap, C. Peter Verrijzer · 2016 · Genes & Development
14. 3-[(1 <i>S</i> ,2 <i>S</i> ,3 <i>R</i> )-2,3-Difluoro-1-hydroxy-7-methylsulfonylindan-4-yl]oxy-5-fluorobenzonitrile (PT2977), a Hypoxia-Inducible Factor 2α (HIF-2α) Inhibitor for the Treatment of Clear Cell Renal Cell Carcinoma
    Xu, Rui, Wang, Keshi, Rizzi, James P., Huang, Heli, Grina, Jonas A., Schlachter, Stephen T., Wang, Bin, Wehn, Paul M., Yang, Hanbiao, Dixon, Darryl D. et al. · 2019 · Journal of Medicinal Chemistry
15. SENP1 promotes hypoxia-induced cancer stemness by HIF-1α deSUMOylation and SENP1/HIF-1α positive feedback loop
    Chun‐Ping Cui, Carmen Chak‐Lui Wong, Alan Ka‐Lun Kai, Daniel Wai‐Hung Ho, Eunice Yuen-Ting Lau, Yu‐Man Tsui, Lo‐Kong Chan, Tan To Cheung, Ksh Chok, Albert C. Y. Chan et al. · 2017 · Gut
16. Hypoxia-Inducible Factors Have Distinct and Stage-Specific Roles during Reprogramming of Human Cells to Pluripotency
    Julie Mathieu, Wenyu Zhou, Yalan Xing, Henrik Sperber, Amy Ferreccio, Zsuzsa Agoston, Kavitha T. Kuppusamy, Randall T. Moon, Hannele Ruohola‐Baker · 2014 · Cell stem cell
17. Mitochondrial Akt Regulation of Hypoxic Tumor Reprogramming
    Young Chan Chae, Valentina Vaira, M. Cecilia Caino, Hsin‐Yao Tang, Jae Ho Seo, Andrew V. Kossenkov, Luisa Ottobrini, Cristina Martelli, Giovanni Lucignani, Irene Bertolini et al. · 2016 · Cancer Cell
18. Lipid Droplets: A Key Cellular Organelle Associated with Cancer Cell Survival under Normoxia and Hypoxia
    Shiro Koizume, Yohei Miyagi · 2016 · International Journal of Molecular Sciences
19. Hypoxia as a barrier to immunotherapy in pancreatic adenocarcinoma
    Sara K. Daniel, Kevin M. Sullivan, Kevin P. Labadie, Venu Gopal Pillarisetty · 2019 · Clinical and Translational Medicine
20. Hypoxia and Inflammation in Cancer, Focus on HIF and NF-κB
    Laura D’Ignazio, Michael Batie, Sónia Rocha · 2017 · Biomedicines
21. Oxygen availability and metabolic reprogramming in cancer
    Hong Jian Xie, Marie Celeste Simon · 2017 · Journal of Biological Chemistry
22. HIF-1α signaling: Essential roles in tumorigenesis and implications in targeted therapies
    Yan Zhao, Cheng Xing, Yating Deng, Can Ye, Hongling Peng · 2023 · Genes & Diseases
23. Inherent DNA‐binding specificities of the HIF‐1α and HIF‐2α transcription factors in chromatin
    Smythies, James A, Sun, Min, Masson, Norma, Salama, Rafik, Simpson, Peter D, Murray, Elizabeth, Neumann, Viviana, Cockman, Matthew E, Choudhry, Hani, Ratcliffe, Peter J et al. · 2019 · The EMBO Reports
24. Hypoxia signaling pathways: modulators of oxygen-related organelles
    Miriam J. Schönenberger · 2015 · Frontiers in Cell and Developmental Biology
25. Cancer–stromal cell interactions mediated by hypoxia-inducible factors promote angiogenesis, lymphangiogenesis, and metastasis
    Gregg L. Semenza · 2012 · Oncogene
26. The IRP1-HIF-2α Axis Coordinates Iron and Oxygen Sensing with Erythropoiesis and Iron Absorption
    Anderson, Sheila A., Nizzi, Christopher P., Chang, Yuan-I., Deck, Kathryn M., Schmidt, Paul J., Galy, Bruno, Damnernsawad, Alisa, Broman, Aimee T., Kendziorski, Christina, Hentze, Matthias W. et al. · 2013 · Cell Metabolism
27. Endothelial HIF-2α regulates murine pathological angiogenesis and revascularization processes
    Nicolas Skuli, Amar J. Majmundar, Bryan L. Krock, Rickson C. Mesquita, Lijoy K. Mathew, Zachary L. Quinn, Anja Runge, Liping Liu, Meeri N. Kim, Jiaming Liang et al. · 2012 · Journal of Clinical Investigation
28. Hypoxia-inducible factors: a central link between inflammation and cancer
    Triner, Daniel, Shah, Yatrik M. · 2016 · Journal of Clinical Investigation
29. Metabolism in tumor microenvironment: Implications for cancer immunotherapy
    Rongchen Shi, Yi‐Quan Tang, Hongming Miao · 2020 · MedComm
30. Mechanisms of Taxane Resistance
    Maloney, Sara, Spring, Camden, Morejon-Lasso, Lorena, Prosperi, Jenifer · 2020 · Cancers
31. Tumor Hypoxia Regulates Immune Escape/Invasion: Influence on Angiogenesis and Potential Impact of Hypoxic Biomarkers on Cancer Therapies
    Raefa Abou Khouzam, Klaudia K. Brodaczewska, Aleksandra Filipiak-Duliban, Nagwa Ahmed Zeinelabdin, Stéphanie Buart, Cezary A. Szczylik, Claudine Kiéda, Salem Chouaı̈b · 2021 · Frontiers in Immunology
32. Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi’s sarcoma
    Diego Omar Croci, Mariana Salatino, Natalia Rubinstein, Juan Pablo Cerliani, Lucas E. Cavallin, Howard J. Leung, Jing Ouyang, Juan M. Ilarregui, Marta A. Toscano, Carolina I. Domaica et al. · 2012 · The Journal of Experimental Medicine
33. Primary endothelial cell–specific regulation of hypoxia‐inducible factor (HIF)‐1 and HIF‐2 and their target gene expression profiles during hypoxia
    Bartoszewski, Rafal, Moszyńska, Adrianna, Serocki, Marcin, Cabaj, Aleksandra, Polten, Andreas, Ochocka, Renata, Dell'Italia, Louis, Bartoszewska, Sylwia, Króliczewski, Jarosław, Dąbrowski, Michał et al. · 2019 · The FASEB Journal
34. Development of Inhibitors Targeting Hypoxia-Inducible Factor 1 and 2 for Cancer Therapy
    Tianchi Yu, Bo Tang, Xueying Sun · 2017 · Yonsei Medical Journal
35. Hypoxia-regulated target genes implicated in tumor metastasis
    Tsai, Ya-Ping, Wu, Kou-Juey · 2012 · Journal of Biomedical Science
36. ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models
    Danielle L. Peacock Brooks, Luciana P. Schwab, Raisa I. Krutilina, Deanna N. Parke, Aarti Sethuraman, David Hoogewijs, Alexandra Schörg, Lauren Gotwald, Meiyun Fan, Roland H. Wenger et al. · 2016 · Molecular Cancer
37. Endothelial Dysfunction Driven by Hypoxia—The Influence of Oxygen Deficiency on NO Bioavailability
    Anna Janaszak‐Jasiecka, Anna Siekierzycka, Agata Płoska, Iwona T. Dobrucki, Leszek Kalinowski · 2021 · Biomolecules
38. HIF-2α Protects Human Hematopoietic Stem/Progenitors and Acute Myeloid Leukemic Cells from Apoptosis Induced by Endoplasmic Reticulum Stress
    Kevin Rouault‐Pierre, Lourdes López-Onieva, Katie Foster, Fernando Anjos‐Afonso, Isabelle Lamrissi‐Garcia, Martin Serrano-Sanchez, Richard Mitter, Zoran Ivanović, Hubert de Verneuil, John G. Gribben et al. · 2013 · Cell stem cell
39. Hypoxia-Inducible miR-210 Regulates the Susceptibility of Tumor Cells to Lysis by Cytotoxic T Cells
    Muhammad Zaeem Noman, Stéphanie Buart, Pedro J. Romero, Sami Ketari, Bassam Janji, Bernard P. Mari, Fathia Mami‐Chouaib, Salem Chouaı̈b · 2012 · Cancer Research
40. Breast cancer stem cells: Features, key drivers and treatment options
    Jürgen Dittmer · 2018 · Seminars in Cancer Biology
41. A Cyclic Peptide Inhibitor of HIF-1 Heterodimerization That Inhibits Hypoxia Signaling in Cancer Cells
    Miranda, Elena, Nordgren, Ida K., Male, Abigail L., Lawrence, Charlotte E., Hoakwie, Franciane, Cuda, Francesco, Court, William, Fox, Keith R., Townsend, Paul A., Packham, Graham K. et al. · 2013 · Journal of the American Chemical Society
42. The Multiple Roles of Exosomes in Metastasis
    Ulrich H. Weidle, Fabian Birzele, Gwen Kollmorgen, Rüdiger Rüger · 2017 · Cancer Genomics & Proteomics
43. New horizons in hypoxia signaling pathways
    Christopher William Pugh, Peter John Ratcliffe · 2017 · Experimental Cell Research
44. Chromosome 3p Loss–Orchestrated VHL, HIF, and Epigenetic Deregulation in Clear Cell Renal Cell Carcinoma
    James J.-D. Hsieh, Valerie H. Le, Toshinao Oyama, Christopher J. Ricketts, Thai H. Ho, Emily H. Y. Cheng · 2018 · Journal of Clinical Oncology
45. FOXM1 (Forkhead box M1) in Tumorigenesis
    Inken Wierstra · 2013 · Advances in cancer research
46. HIF-1α Promotes Glutamine-Mediated Redox Homeostasis and Glycogen-Dependent Bioenergetics to Support Postimplantation Bone Cell Survival
    Steve Stegen, Nick van Gastel, Guy Eelen, Bart Ghesquière, Flora D’Anna, Bernard Thienpont, Jermaine Goveia, Sophie Torrekens, Riet Van Looveren, Frank P. Luyten et al. · 2016 · Cell Metabolism
47. Hypoxia Promotes Tumor Growth in Linking Angiogenesis to Immune Escape
    Salem Chouaı̈b, Yosra Messai, Sophie Couvé, Bernard J. Escudier, Meriem Hasmim, Muhammad Zaeem Noman · 2012 · Frontiers in Immunology
48. NLRP12 collaborates with NLRP3 and NLRC4 to promote pyroptosis inducing ganglion cell death of acute glaucoma
    Hui Chen, Yang Deng, Xiaoliang Gan, Yonghao Li, Wenyong Huang, Lin Lü, Lai Wei, Lishi Su, Jiawen Luo, Bin Zou et al. · 2020 · Molecular Neurodegeneration
49. PD-L1 expression is regulated by hypoxia inducible factor in clear cell renal cell carcinoma
    Ruf, Melanie, Moch, Holger, Schraml, Peter · 2016 · International Journal of Cancer
50. Common pitfalls in preclinical cancer target validation
    Kaelin, William G. · 2017 · Nature Reviews Cancer
51. HIF1α is required for osteoclast activation by estrogen deficiency in postmenopausal osteoporosis
    Yoshiteru Miyauchi, Yuiko Sato, Tami Kobayashi, Shigeyuki Yoshida, Tomoaki Mori, Hiroya Kanagawa, Eri Katsuyama, Atsuhiro Fujie, Wu Hao, Kana Miyamoto et al. · 2013 · Proceedings of the National Academy of Sciences
52. LncRNA RP11-89 facilitates tumorigenesis and ferroptosis resistance through PROM2-activated iron export by sponging miR-129-5p in bladder cancer
    Wenjie Luo, Jun Wang, Wenhao Xu, Chunguang Ma, Fangning Wan, Yongqiang Huang, Mengfei Yao, Hailiang Zhang, Yuanyuan Qu, Dingwei Ye et al. · 2021 · Cell Death and Disease
53. Ferroptosis: Emerging mechanisms, biological function, and therapeutic potential in cancer and inflammation
    Xin Jin, Jiuren Tang, Xiangyu Qiu, Xiaoya Nie, Shengming Ou, Geyan Wu, Rongxin Zhang, Jinrong Zhu · 2024 · Cell Death Discovery
54. Hypoxia-induced autophagy drives colorectal cancer initiation and progression by activating the PRKC/PKC-EZR (ezrin) pathway
    Komal Qureshi-Baig, Diana Kuhn, Elodie Viry, Vitaly Igorevich Pozdeev, Martine Schmitz, Fabien Rodriguez, Pit Ullmann, Eric Koncina, Martin Nurmik, Sónia Frasquilho et al. · 2019 · Autophagy
55. Hypoxia, endoplasmic reticulum stress and chemoresistance: dangerous liaisons
    Muhlis Akman, Dimas Carolina Belisario, Iris C. Salaroglio, Joanna Kopecka, Massimo Donadelli, Enrico De Smaele, Chiara Riganti · 2021 · Journal of Experimental & Clinical Cancer Research
56. Hypoxia-Inducible Factor Signaling in Pheochromocytoma: Turning the Rudder in the Right Direction
    Ivana Jochmanová, Chunzhang Yang, Zhengping Zhuang, Karel Pacák · 2013 · JNCI Journal of the National Cancer Institute
57. Iron and Cancer: 2020 Vision
    Suzy V. Torti, Frank M. Torti · 2020 · Cancer Research
58. Hypoxia-inducible factors: key regulators of myeloid cells during inflammation
    Lin, Nan, Simon, M. Celeste · 2016 · Journal of Clinical Investigation
59. Current Approaches and Recent Developments in the Management of Head and Neck Paragangliomas
    David Taïeb, Alexandre Kaliski, Carsten C. Boedeker, Victoria L. Martucci, Tito Fojo, John R. Adler, Karel Pacák · 2014 · Endocrine Reviews
60. Hypoxia promotes glioma-associated macrophage infiltration via periostin and subsequent M2 polarization by upregulating TGF-beta and M-CSFR
    Xiaofan Guo, Hao Xue, Qianqian Shao, Jian Wang, Xing Guo, Xi Chen, Jinsen Zhang, Shugang Xu, Tong Li, Ping Zhang et al. · 2016 · Oncotarget
61. Modulation of the tumor vasculature and oxygenation to improve therapy
    Siemann, Dietmar W., Horsman, Michael R. · 2015 · Pharmacology &amp; Therapeutics
62. The cancer stem cell niche(s): The crosstalk between glioma stem cells and their microenvironment
    Alina Filatova, Till Acker, Boyan K. Garvalov · 2012 · Biochimica et Biophysica Acta (BBA) - General Subjects
63. Differential but complementary HIF1α and HIF2α transcriptional regulation
    Downes, Nicholas L., Laham-Karam, Nihay, Kaikkonen, Minna U., Ylä-Herttuala, Seppo · 2018 · Molecular Therapy
64. Boolean Network Model for Cancer Pathways: Predicting Carcinogenesis and Targeted Therapy Outcomes
    Herman Fialho Fumiã, Marcelo Lobato Martins · 2013 · PLoS ONE
65. Hif-2α Promotes Degradation of Mammalian Peroxisomes by Selective Autophagy
    Katharina Walter, Miriam J. Schönenberger, Martin Trötzmüller, Michael Horn, Hans‐Peter Elsässer, Ann B. Moser, Miriam S. Lucas, Tobias Schwarz, Philipp A. Gerber, Phyllis L. Faust et al. · 2014 · Cell Metabolism
66. Genetic and metabolic hallmarks of clear cell renal cell carcinoma
    Danielle J. Sanchez, Marie Celeste Simon · 2018 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
67. HIF-2α promotes conversion to a stem cell phenotype and induces chemoresistance in breast cancer cells by activating Wnt and Notch pathways
    Yuanyuan Yan, Fangxiao Liu, Li Han, Lin Zhao, Jianjun Chen, Olufunmilayo Ibironke Olopade, Miao He, Minjie Wei · 2018 · Journal of Experimental & Clinical Cancer Research
68. Pilot trial of EZN-2968, an antisense oligonucleotide inhibitor of hypoxia-inducible factor-1 alpha (HIF-1α), in patients with refractory solid tumors
    Jeong, Woondong, Rapisarda, Annamaria, Park, Sook Ryun, Kinders, Robert J., Chen, Alice, Melillo, Giovanni, Turkbey, Baris, Steinberg, Seth M., Choyke, Peter, Doroshow, James H. et al. · 2014 · Cancer Chemotherapy and Pharmacology
69. HIF‐prolyl hydroxylases as therapeutic targets in erythropoiesis and iron metabolism
    Volker H. Haase · 2017 · Hemodialysis International
70. Intertwined regulation of angiogenesis and immunity by myeloid cells
    Lee B. Rivera, Gabriele Bergers · 2015 · Trends in Immunology
71. New Syndrome of Paraganglioma and Somatostatinoma Associated With Polycythemia
    Karel Pacák, Ivana Jochmanová, Tamara Prodanov, Chunzhang Yang, Maria J. Merino, Tito Fojo, Josef T. Prchal, Arthur S. Tischler, Ronald M. Lechan, Zhengping Zhuang · 2013 · Journal of Clinical Oncology
72. Hypoxia and lymphangiogenesis in tumor microenvironment and metastasis
    Rui‐Cheng Ji · 2013 · Cancer Letters
73. Pyruvate and metabolic flexibility: illuminating a path toward selective cancer therapies
    Olson, Kristofor A., Schell, John C., Rutter, Jared · 2016 · Trends in Biochemical Sciences
74. Tumor suppressor functions of FBW7 in cancer development and progression
    Zhiwei Peter Wang, Hiroyuki Inuzuka, Jiateng Zhong, Lixin Wan, Hidefumi Fukushima, Fazlul H. Sarkar, Wenyi Wei · 2012 · FEBS Letters
75. Ferroptosis: a double-edged sword mediating immune tolerance of cancer
    Qin Dang, Ziqi Sun, Yang Wang, Libo Wang, Zaoqu Liu, Xinwei Han · 2022 · Cell Death and Disease
76. EML4-ALK enhances programmed cell death-ligand 1 expression in pulmonary adenocarcinoma via hypoxia-inducible factor (HIF)-1α and STAT3
    Jaemoon Koh, Ji-Young Jang, Bhumsuk Keam, Sehui Kim, Moon‐Young Kim, Heounjeong Go, Tae Min Kim, Dong‐Wan Kim, Chul Woo Kim, Yoon Kyung Jeon et al. · 2015 · OncoImmunology
77. The Distinct Role of HIF-1α and HIF-2α in Hypoxia and Angiogenesis
    Mouayad Zuheir Bakleh, Ayman Al Haj Zen · 2025 · Cells
78. ALDOA functions as an oncogene in the highly metastatic pancreatic cancer
    Shunrong Ji, Bo Zhang, Jiang Liu, Yi Qin, Chen Liang, Si Shi, Kaizhou Jin, Dingkong Liang, Wenyan Xu, Huaxiang Xu et al. · 2016 · Cancer Letters
79. The p53 family and the hypoxia-inducible factors (HIFs): determinants of cancer progression
    Ivano Amelio, Gerry Melino · 2015 · Trends in Biochemical Sciences
80. Obstructive sleep apnea and cognitive impairment: Addressing the blood–brain barrier
    Diane C Lim, Allan I Pack · 2013 · Sleep Medicine Reviews
81. Iron homeostasis and tumorigenesis: molecular mechanisms and therapeutic opportunities
    Caiguo Zhang, Fan Zhang · 2014 · Protein & Cell
82. Cancer Drug Development of Carbonic Anhydrase Inhibitors beyond the Active Site
    Srishti Singh, Carrie L. Lomelino, Mam Y. Mboge, Susan Cooke Frost, ROBERT V. McKENNA · 2018 · Molecules
83. Hypoxia Inducible Factor Signaling Modulates Susceptibility to Mycobacterial Infection via a Nitric Oxide Dependent Mechanism
    Philip M. Elks, Sabrina Brizee, Michiel van der Vaart, Sarah R. Walmsley, Fredericus J. van Eeden, Stephen A. Renshaw, Annemarie H. Meijer · 2013 · PLoS Pathogens
84. HIF1α and HIF2α independently activate SRC to promote melanoma metastases
    Hanna, Sara C., Krishnan, Bhavani, Bailey, Sean T., Moschos, Stergios J., Kuan, Pei-Fen, Shimamura, Takeshi, Osborne, Lukas D., Siegel, Marni B., Duncan, Lyn M., O’Brien, E. Tim et al. · 2013 · Journal of Clinical Investigation
85. Hypoxia-inducible factors: Crosstalk between inflammation and metabolism
    Jessica E.S. Shay, Marie Celeste Simon · 2012 · Seminars in Cell and Developmental Biology
86. mTORC1 Promotes Metabolic Reprogramming by the Suppression of GSK3-dependent Foxk1 Phosphorylation
    He, Long, Gomes, Ana P., Wang, Xin, Yoon, Sang Oh, Lee, Gina, Nagiec, Michal J., Cho, Sungyun, Chavez, Andre, Islam, Tasnia, Yu, Yonghao et al. · 2018 · Molecular Cell
87. Helix–loop–helix proteins and the advent of cellular diversity: 30 years of discovery
    Cornelis Murre · 2019 · Genes & Development
88. The P2X7 receptor is a key modulator of aerobic glycolysis
    Francesca Amoroso, Simonetta Falzoni, Elena Adinolfi, Davide Ferrari, Francesco Di Virgilio · 2012 · Cell Death and Disease
89. The transition from HIF-1 to HIF-2 during prolonged hypoxia results from reactivation of PHDs and HIF1A mRNA instability
    Jaśkiewicz, Maciej, Moszyńska, Adrianna, Króliczewski, Jarosław, Cabaj, Aleksandra, Bartoszewska, Sylwia, Charzyńska, Agata, Gebert, Magda, Dąbrowski, Michał, Collawn, James F., Bartoszewski, Rafal · 2022 · Cellular &amp; Molecular Biology Letters
90. Hypoxia as a biomarker for radioresistant cancer stem cells
    Claudia Peitzsch, Rosalind L. Perrin, Richard Peter Hill, Anna Dubrovska, Ina Kurth · 2014 · International Journal of Radiation Biology
91. Hypoxia inducible factor (HIF) in the tumor microenvironment: friend or foe?
    Yanqing Huang, Daniel Lin, Cullen M. Taniguchi · 2017 · Science China Life Sciences
92. Upregulation of HIF-2α induced by sorafenib contributes to the resistance by activating the TGF-α/EGFR pathway in hepatocellular carcinoma cells
    Dali Zhao, Bo Zhai, Changjun He, Gang Tan, Xian Li Jiang, Shangha Pan, Xuesong Dong, Zheng Wei, Lixin Ma, Haiquan Qiao et al. · 2014 · Cellular Signalling
93. Critical Role of Tumor Microenvironment in Shaping NK Cell Functions: Implication of Hypoxic Stress
    Meriem Hasmim, Yosra Messai, Linda Ziani, Jérôme Thiery, Jean-Henri Bouhris, Muhammad Zaeem Noman, Salem Chouaı̈b · 2015 · Frontiers in Immunology
94. Hypoxia Pathway Proteins As Central Mediators of Metabolism in the Tumor Cells and Their Microenvironment
    Sundary Sormendi, Ben Wielockx · 2018 · Frontiers in Immunology
95. Succinate induces synovial angiogenesis in rheumatoid arthritis through metabolic remodeling and HIF-1α/VEGF axis
    Yi Li, Yang Liu, Chen Wang, Wenrui Xia, Jia‐Yi Zheng, Jie Wu Yang, Baolin Liu, Jianqun Liu, Lifang Liu · 2018 · Free Radical Biology and Medicine
96. p53 mutants cooperate with HIF-1 in transcriptional regulation of extracellular matrix components to promote tumor progression
    Ivano Amelio, Mara Mancini, Varvara Petrova, Rob A. Cairns, П. Н. Вихрева, Sara Nicolai, Alberto Marini, Alexey A. Antonov, John P. C. Le Quesne, Juvenal Dario Baena Acevedo et al. · 2018 · Proceedings of the National Academy of Sciences
97. Molecular Pathways: Hypoxia-Activated Prodrugs in Cancer Therapy
    Natalia Baran, Marina Y Konopleva · 2017 · Clinical Cancer Research
98. Effects of hypoxia and HIFs on cancer metabolism
    Vera Mucaj, Jessica E.S. Shay, Marie Celeste Simon · 2012 · International Journal of Hematology
99. Innate Immune Cells in the Adipose Tissue in Health and Metabolic Disease
    Zoi Michailidou, Mario A. Gomez-Salazar, Vasileia Ismini Alexaki · 2021 · Journal of Innate Immunity
100. Induction and application of ferroptosis in cancer therapy
     Qing Hua Nie, Yue Hu, Xiao Hong Yu, Xiao Li, Xuedong Fang · 2022 · Cancer Cell International